the aid library

LIST OPTIONS

Filter

2963

Executive Summary - Chapter 3 Pharmacological Treatment

R. Ali ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder; WHO (2019) C_WHO

ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder Accessed: 14.03.2019

Download (177)

View PDF (233)

Evaluation clinique de l'enfant, et de sa famille

S. Mares; A. S. Graeff-Martins IACAPAP (2017) C2

Introduction Chapitre A.4 Edition en français Traduction : Eleanor O’Boyle Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA

Download (264)

View PDF (333)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (205)

View PDF (208)

Combined global demand forecasts for antiretroviral medicines and HIV diagnostic in low- and middle-income countries from 2015 to 2020

A. Adesina; J. Stover; M. Auton; et al. World Health Organization (2016) C_WHO

Technical Report AIDS Medicines and diagnostics service September 2016

Download (259)

View PDF (327)

Retrospective Performance Evaluation of the Afghan Sustainable Water Supply and Sanitation Project 2009-2012

USAID (2017) C1

USAID/Afghanistan’s $443 million investment in the Afghan Sustainable Water Supply and Sanitation (SWSS) activity is one of the Agency’s largest single investments in sustainable rural water supply delivery. The project installed about 2,123 wells with hand pumps across Afghanistan from 2009–2... more

Download (200)

View PDF (214)

Evaluation on the Unicef valuation of the UNICEF PMTCT / paediatric HIV care and Treatment programme

Unicef (2017)

Evaluation Report Evaluation Office

Download (387)

View PDF (317)

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Recommended Antibiotic Treatments in Neonatal and Pediatric Patients

Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy (2021) CC

Download (207)

View PDF (269)

Key technical issues of herbal medicines with reference to interaction with other medicines

World Health Organization WHO (2020) C_WHO

Download (271)

View PDF (159)

Manual del Vacunador: Primer Refuerzo en Niños y Niñas de 5 a 11 Años - Campaña Nacional de Vacunación contra la COVID-19

Feraud, H. Ministerio de Salud Argentina (2022) C2

La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.

Download (79)

View PDF (71)

Progrès accomplis en matière de prévention et de maîtrise des maladies non transmissibles - Rapport du Secrétaire général

United Nations Secretary-General United Nations General Assembly (2017) C_WHO

Le document, intitulé « Progrès dans la prévention et le contrôle des maladies non transmissibles », rend compte des efforts mondiaux pour réduire l’impact des MNT (maladies non transmissibles), telles que les maladies cardiaques, le cancer, le diabète et les maladies respiratoires chroniq... more

Download (475)

View PDF (504)

National Environmental Quality (Emission) Guidelines

The Republic of the Union of Myanmar, Ministry of Environmental Conservation and Forestry (2015) C1

No publication year indicated.

Download (462)

View PDF (636)

Recommandations de l’OMS concernant les soins prénatals pour que la grossesse soit une expérience positive

Organisation mondiale de la Santé (OMS) (2017) C_WHO

Le présent document expose des recommandations exhaustives de l’OMS sur les soins prénatals systématiques à l’intention des femmes enceintes et des adolescentes. Le but de ces recommandations est de compléter les directives de l’OMS existantes sur la prise en charge des complications spé... more